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Abstract
Background: Smoking prevalence is high among Pakistani and Bangladeshi men in the UK, but there are few
tailored smoking cessation programmes for Pakistani and Bangladeshi communities. The aim of this study was to
pilot a cluster randomised controlled trial comparing the effectiveness of Pakistani and Bangladeshi smoking
cessation outreach workers with standard care to improve access to and the success of English smoking cessation
services.
Methods: A pilot cluster randomised controlled trial was conducted in Birmingham, UK. Geographical lower layer
super output areas were used to identify natural communities where more than 10% of the population were of
Pakistani and Bangladeshi origin. 16 agglomerations of super output areas were randomised to normal care
controls vs. outreach intervention. The number of people setting quit dates using NHS services, validated
abstinence from smoking at four weeks, and stated abstinence at three and six months were assessed. The impact
of the intervention on choice and adherence to treatments, attendance at clinic appointments and patient
satisfaction were also assessed.
Results: We were able to randomise geographical areas and deliver the outreach worker-based services. More
Pakistani and Bangladeshi men made quit attempts with NHS services in intervention areas compared with control
areas, rate ratio (RR) 1.32 (95%CI: 1.03-1.69). There was a small increase in the number of 4-week abstinent smokers
in intervention areas (RR 1.30, 95%CI: 0.82-2.06). The proportion of service users attending weekly appointments
was lower in intervention areas than control areas. No difference was found between intervention and control
areas in choice and adherence to treatments or patient satisfaction with the service. The total cost of the
intervention was £124,000; an estimated cost per quality-adjusted life year (QALY) gained of £8,500.
Conclusions: The intervention proved feasible and acceptable. Outreach workers expanded reach of smoking
cessation services in diverse locations of relevance to Pakistani and Bangladeshi communities. The outreach worker
model has the potential to increase community cessation rates and could prove cost-effective, but needs
evaluating definitively in a larger, appropriately powered, randomised controlled trial. These future trials of outreach
interventions need to be of sufficient duration to allow embedding of new models of service delivery.
Trial registration: Current Controlled Trials ISRCTN82127540
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There are marked ethnic and gender variations in smok-
ing prevalence in the UK. In 2004, smoking prevalence
was 40% in Bangladeshi men and 29% in Pakistani men
compared with 24% in the general male population [1].
Stopping smoking is especially important in Pakistani
and Bangladeshi groups because the incidence of heart
disease, stroke and type 2 diabetes is higher than in
other population groups [2,3], and stopping smoking
would reduce the risk of these diseases by more than a
third [4,5]. The UK has a national network of National
Health Service (NHS) smoking cessation services offer-
ing interventions proven to be effective in facilitating
smoking cessation [6-10]. Overall, only about 3% of
smokers use the NHS stop smoking services (SSS),
although over 40% try to quit without use of the SSS
each year [11]. At the time of planning the trial, South
Asian groups (i.e. mainly those of Indian, Pakistani, and
Bangladeshi origin) were half as likely to use the cessa-
tion services than the rest of the population [12]. There
might be specific cultural beliefs that deter Bangladeshi
and Pakistani smokers from using NHS cessation ser-
vices. Qualitative research has shown that Bangladeshi
and Pakistani adults were well aware of the dangers of
smoking and were motivated to quit, but tended to
focus on using willpower and were uncertain about the
value of support and cessation medications [13]. There
is no recognised and implemented model that has been
shown to challenge these types of beliefs about using
the NHS cessation services.
A systematic review reported that interventions to
increase service uptake and rates of cessation among
disadvantaged groups have shown varying success [14].
One study found that proactively identifying smokers
through primary care practice records and providing
these smokers with brief advice and referral to a smok-
ing cessation advisor increased contacts with the ser-
vices and the number of quit attempts, but did not
increase cessation rates [15]. Two studies included in
the review [14] focused primarily on interventions
designed to increase service uptake and cessation in
minority ethnic groups [16,17]. One uncontrolled
before-after study used social marketing, tailored to cul-
tural beliefs, to highlight the dangers of smoking in
Turkish and Kurdish communities in London [16]. The
follow-up survey showed that out of 142 respondents
(47% of original sample), half had recognised the adver-
tising materials used in the campaign and 13% reported
that they had given up smoking. The second study ran-
domised African American communities in the US to a
marketing campaign of adverts, posters and outreach
aimed at increasing calls to a Cancer Information Ser-
vice quit line or to control [17]. The volume of calls
from African Americans to the quit line was signifi-
cantly higher in experimental communities (558 calls)
than in control communities (7 calls, P < 0.008), but no
data on quitting were presented.
We undertook a pilot trial of an intervention designed
to offer a culturally tailored, trained community smok-
ing cessation worker model of care. A Cochrane review
reported that community lay health workers have been
effective in primary care, promoting the uptake of
immunisation and for improving outcomes for selected
infectious diseases in comparison with usual care [18].
Only one randomised controlled trial included in the
review examined the use of lay workers in encouraging
s m o k e r st oq u i t[ 1 9 ] .I nt h i sU Ss t u d y ,2 2c h u r c hc o m -
munities were randomly allocated to either an intensive
intervention involving the use of smoking cessation lay
workers or distribution of self-help materials only. The
study reported no difference in quit rates, but the inter-
vention communities were more likely to intend to quit
in the future. Similarly, another recent review [20] that
examined the impact of lifestyle advisors on health
improvement identified four randomised controlled
trials where lay advisors were used to promote smoking
cessation [21-24]. Three of these studies found that lay
advisor interventions improved quit rates compared to
the control [22-24]. One study involved lay health work-
ers delivering home-based smoking cessation pro-
grammes, tailored specifically to the cultural beliefs and
practices of Latino smokers in the US [24]. One week
abstinence rates were twice as high in the intervention
g r o u p( 2 0 . 5 % )c o m p a r e dt oah e l p l i n ec o n t r o lg r o u p
(8.7%, P < 0.005). In the UK, NHS SSS have developed
community outreach interventions with lay workers, but
these are currently not evaluated. These include facilita-
tors aiming to improve access to existing mainstream
smoking cessation services and the development of par-
allel home-based specialist services.
Building on these wider insights, we developed and
piloted a model of community SSS for Bangladeshi and
Pakistani male smokers and their wider communities.
We focused on men because the prevalence of smoking
in these ethnic groups is substantially higher than in
women [1]. Also, the stigma of Pakistani and Banglade-
shi women smoking [25] means that these women rarely
present for treatment [12].
We describe here the quantitative outcomes and pro-
cesses involved in this pilot cluster randomised con-
trolled trial of trained community outreach workers.
The aim was to examine whether the intervention led
more Pakistani and Bangladeshi men to stop smoking
with NHS support compared to standard care. We also
assessed whether the intervention had an impact on the
type of treatments chosen, adherence to treatments,
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tion with the service. We in addition conducted a longi-
tudinal qualitative study in parallel with the trial to
explore the approach outreach workers took when
recruiting service users and supporting smoking cessa-
tion, and to explore how their role and the intervention
changed over time; the results from this qualitative
work are reported in detail elsewhere [26,27].
Methods
Study design
This was an exploratory Phase II cluster randomised
controlled trial, as defined by the MRC Framework for
Complex Interventions [28-30]. The setting was Bir-
mingham East and North Primary Care Trust (BEN
PCT) and the Heart of Birmingham Teaching Primary
Care Trust (HoB tPCT). A detailed trial protocol has
been published [31]. It was designed to test the accept-
ability and feasibility of the intervention and the devel-
opment of the intervention during the trial was part of
the approach [26]. It was also designed to assess the fea-
sibility and acceptability of the trial methods. It was not
designed to provide definitive evidence of efficacy and
h e n c ew et h e r e f o r ed i dn o tu n d e r t a k ea n ys a m p l es i z e
calculations.
We randomised natural communities to either stan-
dard behavioural support and medication available in
NHS clinics (internal control), or to the same service
augmented by community-based outreach workers,
aiming to encourage and support male Pakistani and
Bangladeshi smokers to quit smoking (intervention).
We selected these areas to be as widely dispersed as
possible, but they were still geographically close and
hence it was possible that this would lead to contami-
nation (i.e. the beneficial effects of outreach also being
seen in control communities). Consequently, we mea-
sured the outcome variables in all other Pakistani and
Bangladeshi men in other areas of HoB and BEN PCTs
(external control); some of these areas were a reason-
able distance from the intervention and internal
control areas and were judged unlikely to experience
contamination.
We used two different approaches to collect our out-
come and process data. We obtained anonymised data
on all Pakistani and Bangladeshi residents, aged 18 years
or over in our intervention, control and external control
areas that used an NHS SSS. These data, collected routi-
nely by the NHS SSS, contained information on the
service users’ age, ethnicity, postcode, quit date and
smoking status at four weeks after the quit date. The
NHS SSS tried to contact all service users who were
abstinent at four-weeks in our intervention, control and
external control areas for verification of quit status at
three-month and six-month follow-up.
We collected more detailed process data on service
use patterns and on satisfaction with the service from a
sample of clinics operating in the intervention, control
and external control areas. These clinics were chosen
because they had treated several Pakistani and Banglade-
shi smokers prior to the study. All participating service
providers were given a pack containing a brief proce-
dure guide, information sheets, consent forms, data col-
lection forms and a method to contact the research
team. Pakistani and Bangladeshi smokers aged 18 years
or over were asked to participate by their service provi-
der during routine consultation. These data were not
anonymised and hence service users gave their consent
to give the data. Service providers recorded weekly
attendance, choice of treatments and adherence (where
adherence was defined as good or less than good for
each type of treatment). At three-month follow-up, ser-
vice users were contacted by NHS SSS to collect infor-
mation on their experiences of using the service, which
was recorded on a patient satisfaction questionnaire
developed by the research team.
Randomisation
Census lower layer super output areas (LSOAs) were
used as the unit of allocation [32]. LSOAs are the smal-
lest unit of census geography consisting of 400 house-
holds on average. LSOAs within the two PCTs, where
the combined Pakistani and Bangladeshi population was
more than 10% of the total, were mapped. Contiguous
LSOAs were aggregated into natural communities (i.e.
areas where people live, work, shop, etc.) using local
knowledge. We created buffer zones around the trial
areas to reduce the risk of contamination.
There were eight agglomerations of LSOAs in which
more than 30% of the population were Pakistani and
Bangladeshi and eight low density areas where 10-29%
of the population from these groups lived. The 16 areas
were stratified, firstly by the proportion of Pakistani and
Bangladeshi residents and secondly, by absolute popula-
tion size into two further strata. The trial statistician
used permuted blocks of four to randomise eight areas
to intervention and eight to control. Despite the stratifi-
cation for size, the total resident population of the con-
trol areas was much larger than in the intervention
areas. The managers of the NHS SSS were unhappy to
work on the smaller target population; therefore, with
the agreement of the Independent Trial Steering Com-
mittee, we swapped the intervention and control areas
status prior to the intervention starting. Maps of the
final areas and their allocation to the two trial arms are
published in our trial protocol [31].
As socio-economic position is a strong predictor of
smoking status, mean Index of Multiple Deprivation
(IMD) scores were calculated for each area to rule out
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sure of deprivation across England. Scores are calculated
using multiple indices of deprivation within seven
domains: income, employment, health and disability,
education skills and training, barriers to housing and
services, living environment, and crime [33].
Intervention group
Four male, community based, stop smoking advisors
(SSAs), known henceforth as ‘outreach workers’,p r o -
vided additional support to NHS SSS, which was other-
wise similar to that provided in the control areas. Two
outreach workers were of Bangladeshi origin and two of
Pakistani origin. Between them, they spoke the main
relevant languages (i.e. Sylheti, Bengali, Punjabi, Mirpuri,
Urdu, and English). The outreach workers were paired
into two teams of one Bangladeshi and one Pakistani
outreach worker in each PCT. Two outreach workers
had worked as SSAs prior to the study. One Pakistani
outreach worker resigned after six months and was
replaced by another Pakistani SSA.
Outreach workers had two weeks of training in deli-
vering behavioural support and medication management
for smoking cessation, general health promotion, com-
munication skills, and the cultural specific norms of
Pakistani and Bangladeshi smokers. The training
involved role-playing the activities in outreach in English
and in minority languages. All outreach workers were
assessed as competent based on these role-plays by the
end of training. The training was delivered by accredited
NHS trainers and the research team.
Two local stop smoking service managers from HoB
tPCT and BEN PCT (referred to henceforth as the
‘management team’) supervised the outreach workers.
The outreach workers and managers met fortnightly
initially then monthly during which the diaries and
experience of the outreach workers were reviewed and
plans made.
The intervention was delivered in two phases,
although this was unplanned at the outset. During the
first phase, i.e. November 2007 to May 2008, outreach
workers concentrated on referring people to existing
services that included pharmacies, drop-in clinics, and
general practices. They did this through producing cul-
turally specific advertising (e.g. posters and leaflets with
relevant images and messages, but written in English;
see discussion), through attending various health related
and non-health related events, and through street and
venue direct outreach (see Table 1). In direct outreach,
the workers set up a stand outside a supermarket, for
example, offering to measure exhaled carbon monoxide
(CO), which naturally led to a conversation about smok-
ing. Also, outreach workers approached Pakistani and
Bangladeshi men either on the street or in workplaces.
They enquired about smoking status, and talked about
quitting smoking. These discussions were conducted in
English or other community languages. Their aim was
to refer smokers to the SSS, but literature was left with
those who accepted it, even if individuals were not
ready to attempt to stop smoking. Outreach workers
kept a copy of referral records and checked on clinic
attendance and re-referred if necessary.
The management team set a target of 1,500 referrals
to the services in the year of the intervention, but
because the actual number of referrals fell far short of
this and because many of those referred did not attend
for treatment the approach changed. The second phase
ran for six months from June 2008 to November 2008
and concentrated on outreach workers combining more
limited outreach with providing treatment for smokers
directly, rather than always referring to NHS services.
The outreach centred on encouraging use of a clinic
that the outreach workers provided in non-NHS venues,
such as barbers’ shops (places of meeting for Pakistani
and Bangladeshi men), mortgage brokers, taxi bases and
bus depots. Sometimes these clinics were held in the
evenings to overcome the problems people working
shifts had in attending clinics. The revised targets were
for outreach workers to treat a minimum of 10 smokers
and achieve five 4-week quitters per month. Further
details on the development of the two phases and out-
reach strategies undertaken are described in our longitu-
dinal qualitative evaluation [26].
Control group
Smokers living in control areas were offered NHS smok-
ing cessation support as normal, which included adver-
tising the availability of treatment through media
campaigns. In these areas of the city, the NHS SSS con-
sisted of healthcare service providers, including general
practitioners (GPs), nurses, pharmacists and specialist
NHS SSAs trained in smoking cessation, and working to
standards set and monitored by the NHS SSS [34].
Data analysis
The two primary outcomes assessed in this pilot RCT
were rates of uptake of services and abstinence propor-
tions at four weeks, and three and six months defined
according to the Russell standard (i.e. using intention-
to-treat and biochemical validation [35]). The uptake
numerator was defined as the number of Pakistani and
Bangladeshi men who set quit dates with the NHS dur-
ing the intervention year that lived in the intervention
and control areas. The denominator was the estimated
number of Bangladeshi and Pakistani smokers in the
areas. As the resultant number is an estimate rather
than a true denominator, we used a Poisson multilevel
model with the log of the estimated number as an offset.
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adjusted for the rates of use in those areas in the 12
months prior to the intervention by including the log of
these rates as a covariate. The geographical areas rando-
mised were included in the model as a random effect,
thereby allowing for the clustering inherent in the
design [36].
The quit proportion was defined as the proportion of
people achieving four weeks, three months, or six
months prolonged abstinence allowing a standard two
week grace period, with a denominator of all those who
attended the service and set a quit date. Self-reporting
at four weeks was verified by expired CO less than 10
parts per million [37]. We assumed that all non-respon-
ders and those who did not provide a validation sample
at four weeks were still smoking. Our NHS partners
were unable to carry out biochemical validation at three
and six months as the protocol indicated. Consequently
these data are based on self-reported prolonged absti-
nence. We used multilevel logistic regression models
because a true denominator was available [38]. We had
intended to adjust for the quit proportion in the inter-
vention and control areas for the year prior to the inter-
vention, but data on biochemical validation were
missing at four weeks for part of the year from one
PCT. Therefore these data were initially adjusted for the
quit proportion achieved in the seven months prior to
the intervention starting (April 2007 to end of October
2007). No baseline data were available for three and six
months.
Our outcome measures examined uptake and cessa-
tion because we hoped that our intervention would
affect uptake by referring more people and the success
rate of those referred by supporting adherence to treat-
ment. The net effect would thus be to increase the
number of smokers stopping with NHS support and this
was also measured as a population rate. The numerator
was the number of people quitting smoking as defined
above and the denominator was the number of smokers
assessed in a Poisson model, as above, initially adjusted
for the numbers stopping smoking in the seven months
prior to the intervention.
The intervention had two distinct phases so, although
not planned in the protocol, we examined uptake of ser-
vices and 4-week quit rates by trial arm, in these two
periods.
Technically, the models were fitted in SAS
® version 9.1,
using PROC GLIMMIX. The Kenward-Roger method
was used to correct for standard error bias [39].
Our process measures examined the use of smoking
cessation treatments, adherence to treatments, atten-
dance at clinic appointments and patient satisfaction
with the service. We calculated the proportion of service
users choosing each available treatment option. Adher-
ence to treatments was modelled with random effects
logistic regression, with the numerator being the num-
ber of people who adhered well to treatment in each
week and the denominator being all those receiving
treatment. Repeated measures on the same individuals
were correlated within individuals and were accounted
Table 1 Description of methods used by outreach workers
Intervention phase Methods and approaches
Phase 1 (November
2007-May 2008)
Mapping the location of existing stop smoking services and meeting with local service providers within intervention
areas.
Networking with small Asian businesses and Bangladeshi and Pakistani community organisations to promote the stop
smoking services.
Developing promotional materials for distribution e.g. posters and leaflets.
Engaging in ‘street outreach’ - approaching people on main roads and side streets, signposting the stop smoking
services
Providing ‘brief intervention’ -counselling smokers to quit using relevant languages (English, Urdu, Mir-puri, Bengali,
Sylheti), identifying suitable quit dates, distributing custom-made literature and support material (e.g. Call 2 Quit
telephone number)
Carrying out weekly follow-up and behavioural support for smokers referred on to services by telephone and SMS text
messaging
Organising promotional events at health centres and baby clinics to promote smoking cessation and highlight dangers
of passive smoking to female relatives of smokers
Accompanying health professionals (e.g. Healthy Heart workers) at events and fairs to promote stop smoking services
Phase 2 (June 2008-
October 2008)
Identifying suitable venues for smoking cessation clinics
Organising promotional events at mosques, leisure centres and libraries, with aim of raising awareness and promoting
own smoking cessation clinics
Providing smoking cessation treatment (nicotine replacement therapy) and behavioural support using relevant
languages in smoking cessation clinics
Engaging in street outreach to signpost people to own or existing smoking cessation clinics
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culate rates for attendance. Items from the patient satis-
faction questionnaire were grouped according to
convenience of service, quality of SSA and overall satis-
faction. These data were analysed using c
2 tests for cate-
gorical data [40]. Data collected from control and
external control areas were also combined for compari-
son with the intervention areas.
Health economic analysis
We adopted the perspective of the NHS as payer and
assessed the costs of the intervention, with benefits and
costs discounted at 3.5%. Because of the nature of the
intervention, we calculated the estimated total costs and
quality adjusted life years (QALYs) gained from the pro-
gramme as a whole. This is different from the approach
usually taken in economic evaluation of healthcare inter-
ventions delivered at the individual level, where costs
and QALYs are calculated per patient. Costs such as the
salary costs of the outreach workers were therefore
included as fixed costs, as they did not change with the
number of smokers recruited, while costs such as addi-
tional treatment costs were multiplied by the number of
people treated. We modelled from the short-term absti-
nence rate the projected long-term abstinence rate using
data from the evaluation of NHS SSS [6] and from stu-
dies with long-term follow up [41] to produce the num-
ber of lifetime abstainers. We assumed no health benefit
from anything other than lifetime abstinence and we
calculated an estimate of the QALYs gained using a pre-
viously developed model [42]. As quit rates are generally
the primary driver of cost-effectiveness estimates [43],
we used the 95% confidence interval of the rate ratio for
abstinence as the only sensitivity analysis of cost-
effectiveness.
Results
Participant flow
Based on the census, there were an estimated 14,000
Pakistani and Bangladeshi men living in the intervention
areas and about 10,000 in the control areas, with 21,000
in the rest of BEN and HoB PCTs. The estimated num-
bers of smokers among them were 4,000, 3,000, and
7,000 respectively. Of these, 271, 169, and 524 Pakistani
and Bangladeshi men in the intervention, control, and
external control areas tried to stop with the support of
the NHS cessation services in the year prior to the inter-
vention (November 2006 to October 2007). The rates of
service use were 63/1000 smokers/year, 58/1000/year,
and 80/1000/year respectively. Of these smokers, in the
seven months prior to the intervention, 63, 45, and 164
in the intervention, control, and external control areas
achieved at least four weeks of biochemically confirmed
abstinence. This was 25, 26, and 42/1000 smokers/year,
and 44%, 42%, and 50% respectively of all smokers that
set a quit date.
Characteristics of intervention and control areas and NHS
SSS users
The intervention areas had a larger population on aver-
age than the control areas, with a mean (SD) of 4,865
(6,042) compared with 3,327 (5,684) in the control
areas. The socio-economic profile was similar with an
IMD mean (SD) score of 56 (10) in the intervention
areas and 50 (6) in the control areas. (A score of 50 or
higher puts these areas in the top third most deprived
in Birmingham, a city with relatively high levels of
deprivation.)
The characteristics of smokers using the cessation ser-
vice were also similar in the intervention and control
areas (Table 2).
In our sub-sample of NHS SSS users, there were 52,
16 and 53 smokers who gave data to their SSAs who
were resident in the intervention, control and external
control areas respectively. In keeping with the popula-
tion of Birmingham, most participants were Pakistani
a n dt h ep o p u l a t i o nw e r ey o u n g e rt h a ns e e ni nm a n y
smoking cessation trials in the NHS SSS and also
slightly less dependent on tobacco (Table 3).
Implementation of the intervention
In phase one of the intervention, outreach workers dis-
cussed smoking cessation with 1,916 people (smokers
and non-smokers), of whom 229 (12%) smokers
accepted referral to the cessation service, and 58 (3%)
attempted cessation. In phase two, outreach workers
approached 1,733 people, where 164 (9%) smokers were
referred to the cessation service, of whom at least 38
(2%) were treated by outreach workers.
Effect of intervention on rate of use of NHS SSS
During the intervention year, the absolute use of the
NHS SSS by residents of control areas decreased by six
to 163 and the rate declined slightly to 56/1000 smo-
kers/year (Figure 1). We might therefore have expected
little change among the intervention areas, but there
was an increase of 70 to 341 with the rate climbing
from 63 to 80/1000 smokers/year. The rate ratio (RR)
and 95% confidence intervals (CI) for service use versus
the internal control was 1.32 (95%CI 1.03, 1.69). There
was also a small decline in the external control area of
26 to 498 users, a rate of 76/1000 smokers/year. The RR
for intervention relative to external control was 1.28
(95%CI 1.02, 1.60).
Quit proportions and quit rates
There was almost no change in the proportion of smo-
kers achieving four weeks of abstinence confirmed by
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Year before study Year of study
Intervention Control External control Intervention Control External control
Number of users 271 169 524 341 163 498
Age in years mean (SD) 36.1 (12.7) 36.2 (12.1) 36.0 (12.8) 35.8 (12.0) 38.0 (14.1) 35.5 (12.0)
Ethnicity n (%)
Bangladeshi 68 (25.1) 42 (24.9) 121 (23.1) 67 (19.6) 35 (21.5) 131 (26.3)
Pakistani 203 (74.9) 127 (75.1) 403 (76.9) 274 (80.4) 128 (78.5) 367 (73.7)
Table 3 Baseline characteristics of sub-sample of service users by trial arm
Intervention Control External control Combined control
All participants (n) 52 16 53 69
Age in years mean (SD) 35.8 (12.6) 34.8 (8.1) 34.2 (11.1) 34.3 (10.4)
Ethnicity n (%)
Bangladeshi 8 (15.4) 9 (56.3) 17 (32.1) 26 (37.7)
Pakistani 44 (84.6) 7 (43.8) 36 (67.9) 43 (62.3)
Marital status n (%)
Single 18 (34.6) 5 (31.3) 20 (37.7) 25 (36.2)
Separated 1 (1.9) 0 (0) 2 (3.8) 2 (2.9)
Married living with partner 28 (53.8) 11(68.8) 31 (58.5) 42 (60.9)
Unknown 5 (9.6) 0 (0) 0 (0) 0 (0)
Partner’s smoking status n (%)
Smoker 1 (1.9) 2 (12.5) 3 (5.7) 5 (7.2)
Non-smoker 33 (63.5) 13 (81.3) 42 (79.2) 55 (79.7)
No partner 8 (15.4) 1 (6.3) 6 (11.3) 7 (10.1)
Unknown 10 (19.2) 0 (0) 2 (3.8) 2 (2.9)
Employment
In paid employment 18 (34.6) 11 (68.8) 27 (50.9) 38 (55.1)
Unemployed 24 (46.2) 3 (18.8) 21 (39.6) 24 (34.8)
Pensioner 0 (0) 0 (0) 1 (1.9) 1 (1.4)
Full time student 5 (9.6) 2 (12.5) 4 (7.5) 6 (8.7)
Unknown 5 (9.6) 0 (0) 0 (0) 0 (0)
Type of Work n (%)
Manual 29 (55.8) 9 (56.3) 37 (69.8) 46 (66.7)
Clerical secretarial 4 (7.7) 0 (0) 3 (5.7) 3 (4.3)
Managerial professional 6 (11.5) 6 (37.5) 3 (5.7) 9 (13.0)
Not worked 5 (9.6) 1 (6.3) 6 (11.3) 7 (10.1)
Unknown 8 (15.4) 0 (0) 4 (7.5) 4 (5.8)
Highest Education n (%)
None 14 (26.9) 6 (37.5) 15 (28.3) 21 (30.4)
GCSE or equivalent 16 (30.8) 5 (31.3) 17 (32.1) 22 (31.9)
A-level or equivalent 8 (15.4) 2 (12.5) 10 (18.9) 12 (17.4)
Degree or equivalent 5 (9.6) 2 (12.5) 6 (11.3) 8 (11.6)
Other 3 (5.8) 0 (0) 5 (9.4) 5 (7.2)
Unknown 6 (11.5) 1 (6.3) 0 (0) 1 (1.4)
FTND* mean (SD) 4.4 (2.7) 4.4 (2.1) 4.6 (2.4) 4.6 (2.3)
Age of starting smoking in years mean (SD) 17.6 (6.5) 18.1 (4.3) 17.6 (5.2) 17.7 (5.0)
Cigarettes per day mean (SD) 15 (10) 16 (5) 17 (7) 17 (7)
Number past quit attempts mean (SD) 1 (1) 1 (1) 1 (1) 1 (1)
Maximum length of previous quit attempt in days, median (range) 21 (1-336) 14 (1-168) 21 (1-672) 21 (1-672)
*Fagerstrom Test for Nicotine Dependence, scored from 0-10.
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Page 7 of 14CO in the control group from the period seven months
prior to the intervention to the period of the interven-
tion: the percentages were 43% prior to and during
the intervention period. In the intervention areas, the
percentage achieving abstinence fell slightly in the
intervention period, from 44% to 39%. The intention
was to adjust for secular trends, but across areas there
was a weak negative association between the percentages
in successive years so no adjustment was made. The
odds ratio (OR) was 0.86 (95%CI 0.52, 1.42) relative to
Assessed for eligibility (16 areas) 
Allocated to intervention (8 areas) 
 
Estimated number of Pakistani and  
Bangladeshi smokers (n=4000) 
 
Received allocated intervention 
 
Participants treated by outreach 
workers and local stop smoking 
service providers (n=341) 
Allocated to control (8 areas) 
 
Estimated number of Pakistani and 
Bangladeshi smokers (n=3000) 
 
Received allocated control 
 
Participants treated by local stop 
smoking service provider (n=163) 
Excluded (n=0) 
Participants lost to follow-up: 
 
4-weeks (n=97) 
3-months (n=97) 
6-months (n=105) 
Participants analysed: 
 
4-weeks (n=341) 
3-months (n=341) 
6-months (n=341) 
Excluded from analysis (n=0)   
 
Participants analysed: 
 
4-weeks (n=163) 
3 months (n=163) 
6-months (n=163) 
Excluded from analysis (n=0) 
 
Randomised (16 areas) 
Participants lost to follow-up: 
 
4-weeks (n=37) 
3-months (n=48) 
6-months (n=51) 
Figure 1 Flow diagram of clusters and participants in the trial.
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Page 8 of 14control areas. In the external control group, the propor-
tion that was successful declined from 50% to 41% and
the OR for intervention relative to the external control
group was 0.92 (95%CI 0.61, 1.38). At three months, 48
(14%) of the intervention area quitters reported pro-
longed abstinence and 38 (11%) did so at six months.
The corresponding numbers for the control areas were
25 (15%) and 14 (9%). The ORs of self-reported pro-
longed abstinence at three and six months for the inter-
vention versus the control were 1.04 (95%CI 0.40, 2.66)
and 1.61 (95%CI 0.50, 5.17). No prior data were avail-
able. Versus the external controls, the ORs were 1.27
(95%CI 0.43, 3.68) for the intervention group and 1.49
(95%CI 0.41, 5.43) for the control group.
The effects on population four-week abstinence rates
combine the uptake rates and outcome of quit attempts.
The control rate decreased slightly from 26 to 24/1000
smokers/year and the intervention rate increased from
25 to 31/1000 smokers/year. The rate ratio for interven-
tion versus control, unadjusted for secular trends was
1.30 (95%CI 0.82, 2.06). In the external controls, the
rate of abstinence declined from 42 to 31/1000 smo-
kers/year and the rate ratio of the intervention group
relative to this was 1.00 (95%CI 0.69, 1.45).
Adherence to treatments, attendance rates and patient
satisfaction
In our sub-sample of NHS SSS users, nicotine patches
were used more often than any other form of nicotine
replacement therapy (NRT) in the intervention (61.5%),
control (56.3%) and external control (73.8%) areas. No
differences were found between groups in the rate at
which people adhered well to treatments at each clinic
appointment (Table 4). The proportion of people
attending weekly clinic appointments was lower in inter-
vention areas compared to control and external control
areas, with less than a third of participants returning for
their subsequent sessions (Table 5).
Most consultations were carried out in English in the
intervention (61.5%), control( 6 2 . 5 % )a n de x t e r n a lc o n -
trol (67.9%) areas, although outreach workers used a
combination of English with another language (25.8%)
more frequently than SSAs (15.3%). These data are
available from the corresponding author.
At three-month follow-up, patient satisfaction data
were collected from 38 (30.6%) service users in our
sub-sample. No differences were found between the
intervention and combined control in the convenience
of the service offered, the quality of SSA or overall
satisfaction (Table 6).
Ancillary analyses
As the intervention developed in two phases, we exam-
ined for evidence that the effect of the intervention rela-
tive to the control and external control varied by phase.
There was no strong evidence for this (Table 7).
Cost-effectiveness
The point estimate of the rate ratio for service use
implies that the effect of the intervention was to
increase the number of smokers trying to quit by 83,
after adjustment for secular trends. Applying the inter-
vention four-week abstinence rates to this number
yielded an additional 32 achieving four-week confirmed
abstinence, which we estimated resulted in an additional
5.6 lifetime abstainers applying relapse rates to one year
[6] and beyond [41]. Using a previous model [42], we
estimated this would yield an additional 14.6 QALYs.
The total cost of the intervention to achieve this was
£124,000; an estimated cost per QALY gained of £8,500.
Applying the upper limit of the 95% confidence interval
gave an estimated cost/QALY gained of £2,000. Apply-
ing the lower limit for the rate ratio for increased use
resulted in an estimated cost/QALY gained of over
£100,000.
Discussion
T h i sp i l o tt r i a lh a sd e m o n s t r a t e dt h a ti tw a sp o s s i b l et o
randomise geographical areas and deliver the NHS SSS
outreach-based model of care to Pakistani and Bangla-
deshi smokers. The effect of the intervention was to
increase the rate of uptake by approximately 30%,
Table 4 Adherence to treatments in sub-sample of service users by trial arm
Sessions of
behavioural support
n (%) good adherence Intervention versus control
Intervention Control External
control
Combined
control
Intervention vs
control
RR (95%CI)
Intervention vs
external control
RR (95%CI)
Intervention vs
combined control
RR (95%CI)
Session 1 51 (98.1) 16
(100)
52 (98.1) 68 (98.6) 0.98 (0.94-1.02) 1.00 (0.95-1.05) 1.00 (0.95-1.04)
Session 2 11 (73.3) 3 (60.0) 14 (82.4) 17 (77.3) 1.22 (0.56-2.66) 0.89 (0.61-1.30) 0.95 (0.65-1.39)
Session 3 10 (76.9) 3 (60.0) 7 (77.8) 10 (71.4) 1.28 (0.59-2.78) 0.99 (0.63-1.56) 1.08 (0.69-1.68)
Session 4 6 (75.0) 4 (80.0) 6 (100.0) 10 (71.4) 0.94 (0.52-1.70) 1.00 (0.57-1.76) 0.97 (0.59-1.61)
Session 5 5 (83.3) 0 (0) 5 (55.6) 5 (55.6) - 1.00 (0.60-1.66) 1.50 (0.76-2.98)
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Page 9 of 14although this was imprecisely estimated. The number of
smokers achieving abstinence as a proportion of all
those trying to quit in the intervention areas was lower
than in the control areas, although the confidence inter-
vals of the odds ratio encompassed unity. This may have
been a result of our recruiting in the intervention areas
smokers with lower motivation to quit using the service.
R e t e n t i o ni nt h eb e h a v i o u r a ls u p p o r tp r o g r a m m ew a s
somewhat lower for outreach workers than for typical
SSS providers, which further suggests that relatively
unmotivated smokers were drawn into the service.
Treatment preference, adherence to treatments and
satisfaction with the cessation service was the same
across all areas.
Overall, there was evidence of a clinically relevant 30%
change in the number of abstinent smokers, but, as
might be expected from a pilot trial, this was not statis-
tically significant. The most likely estimate of the cost-
effectiveness of this intervention would make this inter-
vention highly cost-effective by typical NHS standards
[44], but the imprecision of the estimate precludes firm
conclusions. These data suggest that a full trial may well
be justified, timely and feasible.
The need for a full trial should, however, be considered
in relation to the current context. When we planned the
intervention, we estimated that South Asian smokers
were using the NHS services at only half the rate of the
r e s to ft h ep o p u l a t i o n .S i n c et h e n ,t h eN H SS S Sh a v e
improved their data collection and now it is possible to
provide ethnic-specific rates. In 2007/8 in England, the
rate of use of the NHS SSS was 68/1000 smokers in
White British and 45/1000 in Pakistanis and 56/1000
Bangladeshi smokers. In 2008/9, the rates were 67/1000
in White British, 54/1000 in Pakistanis, and 82/1000 in
Bangladeshis. In 2006/7, in our intervention and control
areas, the rates of use were 63/1000 and 58/1000 and
after the intervention in 2007/8 were 80/1000 and 56/
1000, suggesting that service use by Pakistani and Bangla-
deshi smokers in Birmingham might have been somewhat
higher than the national average before the intervention.
There was very little variation in the English data on quit
rates by ethnic group as a proportion of all those attend-
ing. Another way to consider this is that the RR for the
increase in service use in England as a whole for 2008/9
versus 2007/8 were 1.19 (95%CI 1.15, 1.24) for Pakistanis
and 1.48 (95%CI 1.41, 1.55) for Bangladeshis. These data
indicate that, largely without outreach workers, NHS ser-
vices managed to increase their reach into the Pakistani
and Bangladeshi communities and rates of use by these
groups are now similar to or higher than the White Brit-
ish population nationally.
Our results are similar to another trial, which sought
t or a i s et h eu s eo ft h eN H SS S S[ 1 5 ] .O u rr e s u l t sa l s o
suggested the intervention seemed to raise throughput,
though somewhat at the expense of lowered quit pro-
portion, with no statistically significant effect overall.
Table 5 Attendance at weekly clinics in sub-sample of service users by trial arm
Sessions of
behavioural support
n (%) attendance Intervention versus control
Intervention Control External
control
Combined
control
Intervention
vs control
RR (95%CI)
Intervention vs external
control RR (95%CI)
Intervention vs
combined control
RR (95%CI)
Session 1 52 (100) 16
(100)
53 (100) 69 (100) 1 1 1
Session 2 15 (28.8) 5 (31.3) 17 (32.1) 22 (31.9) 0.92 (0.40-2.14) 0.90 (0.50-1.61) 0.90 (0.52-1.57)
Session 3 13 (25.0) 5 (31.3) 9 (17.0) 14 (20.3) 0.80 (0.34-1.90) 1.47 (0.69-3.14) 1.23 (0.63-2.39)
Session 4 8 (15.4) 5 (31.3) 6 (11.3) 13 (18.8) 0.49 (0.19-1.29) 1.02 (0.41-2.51) 0.82 (0.37-1.82)
Session 5 6 (11.5) 3 (18.8) 8 (15.1) 9 (13.0) 0.62 (0.17-2.19) 1.02 (0.35-2.96) 0.88 (0.34-2.33)
Table 6 Patient satisfaction in sub-sample of service users by trial arm
Intervention Combined control Intervention versus combined control
median (range) c2 p Value
Variable
Convenience of service† 13 (9-15) 12 (6-15) 1.39* 0.24
Quality of stop smoking advisor‡ 28 (23-35) 31 (19-35) 0.49* 0.49
Overall satisfaction§ 8 (6-9) 8 (5-9) 0.64* 0.42
†Three items related to convenience of service. Response categories ranged from 1 (very inconvenient/very dissatisfied) to 5 (very convenient/very satisfied).
‡Five items related to quality of stop smoking advisor. Response categories ranged from 1 (very dissatisfied) to 5 (very satisfied).
§Two items related to overall satisfaction. Response categories ranged from 1 (very dissatisfied) to 5 (very satisfied) and 1 (no would not recommend service) to
4 (yes would recommend service wholeheartedly).
*c2 Test for trend.
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Page 10 of 14Although our intervention targeted Pakistanis and
Bangladeshis, interventions with each group were sepa-
rate, usually in different venues, communicating with
people in their preferred languages. Our outreach work-
ers, for example, produced a range of advertising materi-
als to promote themselves and the cessation services.
They carried out focus groups with members of the
public, community networks and pharmacists to deter-
mine the suitability and relevance of all materials. Most
people they spoke to thought that it would not be effec-
tive to have promotional materials written in commu-
nity languages. They held the view that while many
Pakistanis and Bangladeshis speak in languages particu-
lar to their ethnic group, many of these same people
cannot read or write in their own languages. All adver-
tising materials were therefore written in English, but
they contained culturally relevant images and messages.
The outreach workers did not suggest that the interven-
tion was effective only with one group and not the
other in their exit interviews [26]. We combined the
results for the two ethnic groups as we saw no reason
not to do so. Our qualitative work [26] suggested that
Pakistani and Bangladeshi smokers shared many com-
mon issues with respect to their smoking and stopping
smoking, as found in other qualitative studies [13,45].
Any future trial might therefore reasonably address both
groups in the way that we did.
The strength of this study is that it is one of the few
randomised controlled trials of community interventions
to increase smoking cessation rates in minority and
socio-economically deprived populations. As such it pro-
vides unbiased estimates of the effects of these interven-
tions. However, it was a preliminary study and the small
sample size in the study precludes definitive conclusions
on the effectiveness and cost-effectiveness of the model.
Also, the study took place in one city with areas nearby
to one another randomised to intervention and control
status. Participants were defined by their postcode of
residence and a number of people who lived in control
areas were beneficiaries of the intervention and this
effect would reduce the apparent benefit of the interven-
tion. A further issue is that the year of observation prior
to the intervention included the change to prohibit
smoking in all indoor public places and this had a small
effect on increasing use of NHS SSS [11], though this
would increase the rate of use of the service in both
intervention and control areas and not bias the rate
ratio. This effect might have led to the small decline in
Table 7 Comparison of rates of setting quit dates and achieving 4-week quit rates between the trial arms during the
two phases of the trial
Setting quit date Russell standard abstinence at 4 weeks
RR (95%CI) P-value RR (95%CI) P-value
As a rate of all smokers
Randomised Comparison
Overall 1.32 (1.03, 1.69) 0.03 1.30 (0.82, 2.06) 0.24
1st Phase 1.24 (0.88, 1.75) 0.21 1.36 (0.78, 2.36) 0.25
2nd Phase 1.57 (1.03, 2.41) 0.04 1.25 (0.71, 2.22) 0.42
Versus External Controls
Overall 1.28 (1.02, 1.60) 0.03 1.00 (0.69, 1.45) 0.99
1st Phase 1.06 (0.81, 1.39) 0.66 0.94 (0.60, 1.47) 0.78
2nd Phase 1.36 (0.97, 1.91) 0.07 1.09 (0.67, 1.78) 0.70
Interaction test 0.42 0.70
As proportion of those setting quit date OR (95%CI) P-value
Randomised comparison
Overall 0.86 (0.52, 1.42) 0.53
1st Phase 1.06 (0.58, 1.94) 0.85
2nd Phase 0.60 (0.30, 1.20) 0.14
Versus External Controls
Overall 0.92 (0.61, 1.38) 0.66
1st Phase 0.96 (0.59, 1.56) 0.85
2nd Phase 0.84 (0.48, 1.47) 0.51
Interaction test 0.34
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Page 11 of 14use from before the intervention to during it seen in the
control area.
The aim of this study was to prepare for a definitive
phase III trial and the question arises as to whether we
know enough to take this forward. In favour of this
would be the effect estimates, which show an approxi-
mate 30% increase in rate of use of the NHS SSS and
quit rates in socio-economically deprived populations at
high risk of cardiovascular disease. In favour too would
be the potentially low cost/QALY. However, NHS ser-
vices may view this balance differently. Four workers
working for one year managed to encourage another 83
people to stop smoking with NHS support, or approxi-
mately one person every 2-3 weeks/worker. The workers
found the process of raising awareness and referring
smokers to the service dispiriting because the large
majority of people referred failed to attend. However,
they were more encouraged by running their own clinics
[26], but the results suggest little difference in the effec-
tiveness of these two approaches.
There is a similar and long-running outreach pro-
gramme in Tower Hamlets in London, the borough
with the highest proportion of Bangladeshi residents in
England. This service treated 463 male smokers in
2008/9 out of a total of 1,104 (42%) in Tower Hamlets
[ 4 6 ] .G i v e nt h e s ed a t aa n dt h ed a t ao nt h ei n c r e a s i n g
use of services by Pakistani and Bangladeshi smokers
nationally, it is clear that outreach might have a role to
play, but the mainstay of reaching these smokers is
attracting them to general NHS services and the NHS
has been successful at doing so over the past year.
Conclusions
This pilot cluster randomised controlled trial produced
evidence that outreach workers can encourage Pakistani
and Bangladeshi smokers to use NHS support for cessa-
tion. The increase in use and increase in population quit
r a t e so b t a i n e ds u g g e s t st h a tt h i sk i n do fi n t e r v e n t i o ni s
worth evaluating in a definitive trial. Our experiences
from running this pilot trial, the data now available for
sample size calculations and the insights gained from the
accompanying qualitative work should prove valuable in
planning for our formal randomised controlled trial.
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